Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Steveo10on Mar 26, 2019 1:02pm
91 Views
Post# 29537493

RE:Stop Whining!!

RE:Stop Whining!!
Packerfan666 wrote: This is a Junior Biotech company. They just released great news. It goes up on huge volume and then penny flippers take it down .5-1 cent based on sh$tty small volume. Who Cares!! You either believe or you don’t! We are either going to get FDA approval or we are not.... stop crying over short term losses and partnerships. PENNY get your head out of your as$, they are working behind the scenes to gain a partnership obviously . They still want to get shareholders a good value. So how about instead of spamming boards with your guys complaints , show up to next shareholder meeting and voice them. If you know who to run a biotech better let’s see, I’ll buy some shares 

 
Imo it’s jusr gonna do what it did in dec. Go up to 0.09-0.10 then back in it’s hole.  I didn’t sell this time so I hope I’m wrong
Bullboard Posts